02 June, 2026 | Tuesday | Analysis

When President Trump signed the FY2026 National Defense Authorization Act on December 18, 2025, the biopharmaceutical industry finally got the law it had spent three years anticipating, debating, and quietly he...

02 June, 2026 | Tuesday | News

Thermo Fisher Scientific announced the launch of the Invitrogen™ E-Gel™ Power Snap Lite Electrophoresis System, a compact, all-in-one solution designed for routine nucleic acid verification workflow...

02 June, 2026 | Tuesday | Analysis

A decade ago, the phrase “Chinese first-in-class drug” would have drawn a raised eyebrow in any Western boardroom. China made generics, copied mechanisms, and ran cheap trials. The frontier of biolo...

02 June, 2026 | Tuesday | Analysis

In October 2025, Eli Lilly announced it would build the most powerful supercomputer ever owned by a drug company. By February 2026, “LillyPod” was online — more than 1,000 NVIDIA Blackwell Ult...

27 May, 2026 | Wednesday | News

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Hepcludex® (bulevirtide-gmod) 8.5 mg for the treatment of adults living with chroni...

02 June, 2026 | Tuesday | News

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™:  a High-Throughput ADME Platform That Brings Pharmacokinetic Projection  Earlier in Drug Discovery   New co-d...

28 May, 2026 | Thursday | News

DePuy Synthes secures exclusive commercialization rights in North America and Australia; the two companies to jointly advance global clinical development and regulatory approvals, including FDA IDE and PMA pa...